PhRMA urges USTR to protect US innovation abroad
The Pharmaceutical Research and Manufacturers of America (PhRMA) has urged the US Trade Representative (USTR) to protect US innovators abroad.
PhRMA, which represents US biopharmaceutical research companies, submitted its comments to the USTR for the “2017 Special 301 Report”.
The USTR report, an annually published review of intellectual property protection and enforcement abroad, identifies challenges facing America’s innovative and creative industries in overseas markets.
In the submission, which was handed in on Thursday, February 9, PhRMA focused on the IP and market access barriers in 18 countries which harm biopharmaceutical innovators in the US.
PhRMA recommended these countries, which include Canada, China, Colombia and India, for inclusion on the priority watch list.
Placement on the list indicates that particular problems exist in that country with respect to IP protection, enforcement or market access for people relying on IP.
PhRMA said in a statement: “Too many countries fail to value and respect American ideas, brands and inventions.”
The organisation added that medicines developed and manufactured in the US face a “growing array” of tariffs, taxes and approval delays in overseas markets .
PhRMA has asked the USTR to address these barriers and “ensure America’s trading partners live up to their IP and market access commitments in global, regional and bilateral agreements”.
It has also called for action to improve medicine pricing and reimbursement transparency, as well as combat the worldwide proliferation of counterfeit medicines.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk